About Zoetis Inc. Class A Common Stock
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue.
2BB score and signals
Zoetis Inc. Class A Common Stock’s current 2BB score is 55 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 49 | Moderate |
| Momentum | 55 | Stable |
| Financial strength | 76 | Strong |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
Company facts
| CEO | Kristin C. Peck |
| Headquarters | Parsippany-Troy Hills, New Jersey, United States |
| Founded | 1952 |
| Employees | 14.5K |
| P/E ratio | 12.34 |
| 52-week range | $71.00 – $156.49 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-10 | — | 1.3083 | — | $2.25B |
| 2026-11-02 | — | 1.5234 | — | $2.32B |
| 2026-08-06 | — | 1.8742 | — | $2.53B |
| 2026-05-07 | 1.53 | 1.6309 | $2.26B | $2.33B |
Related companies
